Supernus sets Q3 2024 earnings call for November 4 after market close

SUPERNUS PHARMACEUTICALS, INC.

Earnings release scheduled for Monday, November 4, 2024, after market close.
President/CEO Jack Khattar and CFO Tim Dec to host conference call at 4:30 p.m. ET.
Webcast replay available for 60 days on investor relations website.

item 2.02 item 9.01

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-24-000060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.